Fredrik Widman - Intuitive Surgical Principal VP
| IUI1 Stock | EUR 503.30 2.30 0.45% |
Insider
Fredrik Widman is Principal VP of Intuitive Surgical
| Phone | 408 523 2100 |
| Web | https://www.intuitive.com |
Fredrik Widman Latest Insider Activity
Tracking and analyzing the buying and selling activities of Fredrik Widman against Intuitive Surgical stock is an integral part of due diligence when investing in Intuitive Surgical. Fredrik Widman insider activity provides valuable insight into whether Intuitive Surgical is net buyers or sellers over its current business cycle. Note, Intuitive Surgical insiders must abide by specific rules, including filing SEC forms every time they buy or sell Intuitive Surgical'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Fredrik Widman over a year ago Sale by Fredrik Widman of 1307 shares of Intuitive Surgical | ||
Fredrik Widman over a year ago Sale by Fredrik Widman of 1307 shares of Intuitive Surgical |
Intuitive Surgical Management Efficiency
The company has return on total asset (ROA) of 0.0756 % which means that it generated a profit of $0.0756 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1166 %, meaning that it generated $0.1166 on every $100 dollars invested by stockholders. Intuitive Surgical's management efficiency ratios could be used to measure how well Intuitive Surgical manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Urvashi Tyagi | ResMed Inc | N/A | |
| Petra Kirchhoff | Sartorius Aktiengesellschaft | 54 | |
| David Pendarvis | ResMed Inc | 64 | |
| AM AM | ResMed Inc | 80 | |
| Rene Faber | Sartorius Aktiengesellschaft | 48 | |
| Pascale Boissel | Sartorius Stedim Biotech | N/A | |
| Brett Sandercock | ResMed Inc | 56 | |
| Kaushik Ghoshal | ResMed Inc | 55 | |
| Joachim Kreuzburg | Sartorius Aktiengesellschaft | 58 | |
| Heiko Imhl | Sartorius Stedim Biotech | N/A | |
| Mei Wang | Sartorius Aktiengesellschaft | N/A | |
| AM AM | Resmed Inc DRC | 80 | |
| Stefano Grassi | EssilorLuxottica Socit anonyme | 50 | |
| Ariel Bauer | EssilorLuxottica Socit anonyme | N/A | |
| Paul Saillant | EssilorLuxottica Socit anonyme | 64 | |
| Rainer Lehmann | Sartorius Aktiengesellschaft | 48 | |
| Patricia Spannagel | Sartorius Aktiengesellschaft | N/A | |
| Rene Faber | Sartorius Stedim Biotech | 43 | |
| Manohar Kuppusami | Sartorius Aktiengesellschaft | N/A | |
| Amelie Buton | Sartorius Stedim Biotech | 32 | |
| Olivier Guitard | Sartorius Stedim Biotech | N/A | |
Management Performance
| Return On Equity | 0.12 | |||
| Return On Asset | 0.0756 |
Intuitive Surgical Leadership Team
Elected by the shareholders, the Intuitive Surgical's board of directors comprises two types of representatives: Intuitive Surgical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Intuitive. The board's role is to monitor Intuitive Surgical's management team and ensure that shareholders' interests are well served. Intuitive Surgical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Intuitive Surgical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| David Rosa, Ex Officer | ||
| Gary Guthart, CEO Pres | ||
| Philip Kim, Head Relations | ||
| Julian Nikolchev, Sr Strategy | ||
| Jamie Samath, VP CFO | ||
| MD FACS, Ex Officer | ||
| Gary Loeb, G Officer | ||
| Robert DeSantis, Ex Officer | ||
| Fredrik Widman, Principal VP | ||
| Marshall Mohr, Exec Services |
Intuitive Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Intuitive Surgical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.12 | |||
| Return On Asset | 0.0756 | |||
| Profit Margin | 0.21 % | |||
| Operating Margin | 0.26 % | |||
| Current Valuation | 86.49 B | |||
| Shares Outstanding | 350.39 M | |||
| Shares Owned By Insiders | 0.50 % | |||
| Shares Owned By Institutions | 88.20 % | |||
| Price To Earning | 44.64 X | |||
| Price To Book | 8.30 X |
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in Intuitive Stock
When determining whether Intuitive Surgical is a strong investment it is important to analyze Intuitive Surgical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Intuitive Surgical's future performance. For an informed investment choice regarding Intuitive Stock, refer to the following important reports:Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Intuitive Surgical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For more detail on how to invest in Intuitive Stock please use our How to Invest in Intuitive Surgical guide.You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.